Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 674.00
Bid: 675.00
Ask: 676.00
Change: 0.50 (0.07%)
Spread: 1.00 (0.148%)
Open: 674.00
High: 678.50
Low: 672.50
Prev. Close: 673.50
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital Markets Event

8 Feb 2023 07:00

RNS Number : 2128P
Tate & Lyle PLC
08 February 2023
 

8 February 2023 - Tate & Lyle PLC

 

Tate & Lyle Capital Markets Event

 

Tate & Lyle PLC (Tate & Lyle) is today hosting a Capital Markets event for investors and analysts.

 

The event will focus on the Group's strategy, business model, portfolio, markets, and science-led approach which puts it at the centre of the future of food. The event will be hosted by Nick Hampton, Chief Executive, Dawn Allen, Chief Financial Officer, alongside other members of the Tate & Lyle senior management team. 

 

Nick Hampton, Chief Executive said:

"Over the last five years, Tate & Lyle has been transformed into a growth-focused speciality food and beverage solutions business. A global leader in sweetening, mouthfeel and fortification, Tate & Lyle creates high-value speciality ingredients and solutions that meet growing global demand for healthier and tastier food and drink. 

 

At today's event we look forward to outlining the large and attractive markets we operate in, our portfolio of highly functional speciality ingredients that directly address growing consumer trends, our scientific and solutions capabilities, how we work with customers, and our purpose-driven approach fueling our new focus on 'Science, Solutions, Society'."

 

Performance ambition for the five years ending 31 March 2028

Today, Tate & Lyle is announcing an updated organic performance ambition for the five years ending 31 March 2028 to deliver:

• Revenue growth of 4% to 6% per annum, underpinned by high single digit Food & Beverage Solutions growth per annum

• EBITDA growth of 7% to 9% per annum

• Return on capital employed improvement of up to 50 basis points per annum on average.

• A new target to deliver US$100 million of cumulative productivity benefits

 

Reporting changes

Reflecting its new shape, the Group is adopting a simplified disclosure framework, moving to three segments - Food & Beverage Solutions, Sucralose and Primary Products Europe. As a result of this change, Central costs will no longer be reported separately.

 

Following the Group's recent third quarter trading update on 26 January 2023, no new material trading information or update in respect of the current financial year ending31 March 2023 will be provided during the event.

 

Registration is required to attend the event with details available on our website at https://www.tateandlyle.com/investors-hub. The slides to be presented at the event will be available from the investor relations section of our website shortly before the event, and the webcast of the presentation will be available shortly after the event. 

 

END

 

For more information contact Tate & Lyle PLC:

Christopher Marsh, VP, Investor Relations

Mobile: +44 (0) 7796 192 688

 

Nick Hasell (FTI Consulting), Media Relations

Mobile: +44 (0)7825 523 383

 

About Tate & Lyle:

Tate & Lyle is a world leader in ingredient solutions for healthier food and beverages. Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

Through our expertise in sweetening, mouthfeel and fortification, we develop solutions which reduce sugar, calories and fat, add fibre and protein, and provide texture and stability in categories including beverages, dairy, bakery, soups, sauces and dressings.

We have more than 3,500 employees working in around 57 locations across 39 countries. Tate & Lyle's purpose is Transforming Lives Through the Science of Food and through our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2022, Tate & Lyle revenue from continuing operations totalled £1.4 billion. For more information, please visit https://www.tateandlyle.com or follow Tate & Lyle on Twitter, Linkedin, Facebook or YouTube

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBUGDDUUGDGXR
Date   Source Headline
1st Jul 201310:08 amBUSBlocklisting Interim Review
1st Jul 20139:53 amBUSTotal Voting Rights
28th Jun 20135:32 pmBUSTransaction in Own Shares
27th Jun 20135:18 pmBUSTransaction in Own Shares
26th Jun 20135:16 pmBUSTransaction in Own Shares
25th Jun 20135:32 pmBUSTransaction in Own Shares
24th Jun 20136:06 pmBUSTransaction in Own Shares
21st Jun 20135:51 pmBUSTransaction in Own Shares
20th Jun 20135:35 pmBUSAnnual Financial Report
20th Jun 201310:27 amBUSDirector/PDMR Shareholding
19th Jun 20139:08 amBUSDirector/PDMR Shareholding - Replacement
18th Jun 20135:01 pmBUSDirector/PDMR Shareholding
17th Jun 20133:34 pmBUSHolding(s) in Company
14th Jun 201311:35 amBUSDirector/PDMR Shareholding
7th Jun 20133:06 pmBUSHolding(s) in Company
5th Jun 201312:19 pmBUSHolding(s) in Company
3rd Jun 20131:48 pmBUSDirector/PDMR Shareholding
30th May 20137:00 amBUSFinal Results
24th May 20134:57 pmBUSHolding(s) in Company
21st May 20135:31 pmBUSHolding(s) in Company
17th May 20134:36 pmBUSHolding(s) in Company
16th May 20139:07 amBUSHolding(s) in Company
13th May 20135:20 pmBUSHolding(s) in Company
9th May 20136:03 pmBUSHolding(s) in Company
1st May 201311:44 amBUSTotal Voting Rights
26th Apr 20132:28 pmBUSHolding(s) in Company
2nd Apr 20134:25 pmBUSHolding(s) in Company
2nd Apr 201310:04 amBUSTotal Voting Rights
28th Mar 20137:00 amBUSTrading Statement
20th Mar 20133:42 pmBUSDirector Declaration
5th Mar 20132:35 pmBUSDirector/PDMR Shareholding
5th Mar 20132:30 pmBUSHolding(s) in Company
1st Mar 201311:18 amBUSDirector/PDMR Shareholding
1st Mar 201310:00 amBUSDirector/PDMR Shareholding
1st Mar 20139:00 amBUSTotal Voting Rights
25th Feb 20133:13 pmBUSHolding(s) in Company
11th Feb 20139:42 amBUSDirector/PDMR Shareholding
1st Feb 20139:20 amBUSTotal Voting Rights
1st Feb 20137:00 amBUSInterim Management Statement
17th Jan 20133:07 pmBUSHolding(s) in Company
17th Jan 20132:01 pmBUSHolding(s) in Company
14th Jan 201310:44 amBUSDirector/PDMR Shareholding
8th Jan 20135:00 pmBUSDirector/PDMR Shareholding
2nd Jan 20133:56 pmBUSBlocklisting Interim Review
28th Dec 201210:27 amBUSHolding(s) in Company
17th Dec 201212:59 pmBUSDirector/PDMR Shareholding
7th Dec 20122:17 pmBUSDirector/PDMR Shareholding
7th Dec 20127:00 amBUSTate & Lyle Group Pension Scheme agrees £347 million partial pensioner buy-in
6th Dec 20127:00 amBUSTate & Lyle Capital Markets Day
3rd Dec 20129:33 amBUSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.